Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Gene Ther. 2008 Dec 11;16(2):262–278. doi: 10.1038/gt.2008.165

Figure 3.

Figure 3

Transcriptional targeting of oncolytic vectors. Survivin and CXCR4 transcriptional activity in NSCs, human glioma and normal tissue. Quantitative RT-PCR analysis was performed to measure the transcriptional activity of survivin and CXCR4 in NSCs, glioma cells lines (U87MG, U373MG), human glioblastoma multiforme tissue specimen (GBM) and normal brain tissue (NB). *P-value <0.05 vs CXCR4.